Capa, Vidie .
HRN: 14-41-70 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2024
CEFTRIAXONE 1G (VIAL)
01/03/2024
01/09/2024
IVT
900mg
Q12hrs
Pcap C With HRAD
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes